---
title: "\"ROI Case Studies for Pharma Commercial Teams | Within3\""
description: Four ungated ROI case studies on how pharma commercial teams use Within3's Launch Intelligence™ platform to move faster and protect revenue.
---

[![Within3](https://resources.within3.com/hs-fs/hubfs/W3%20Logo-1.png?width=800&height=282&name=W3%20Logo-1.png "Within3")](https://within3.com/)

Open main menu Close main menu

## See exactly how commercial teams turned scattered data into faster action

## Four launch challenges. One Source of Truth

Slow uptake. Competitive share loss. Undiagnosed patients. Uneven evidence uptake. Four ROI case studies on how commercial teams used Within3's Launch Intelligence™ platform to find the real problem underneath the numbers, then act on it before the launch window closed.

● Access all four case studies below. No form required.

 

![Untitled design (7)](https://resources.within3.com/hubfs/Untitled%20design%20(7).png "Untitled design (7)")

Typical vendor stacking can cost you between $700K–$1.9M/yr. Within3 delivers this as one solution.

![neurology](https://resources.within3.com/hs-fs/hubfs/neurology.png?width=400&height=486&name=neurology.png "neurology")

## 1. Neurology

## Navigating Uptake Barriers and Accelerating Adoption

### A neurology team moved beyond prescription data to uncover the real barriers slowing physician adoption, and built a segmentation strategy precise enough to overcome them.

[Read More](https://resources.within3.com/hubfs/2026%20-%202H%20-%20ROI%20Commercial%20Use%20Cases%20(4%20of%204)/W3-One-Pager-Use-Case-Uptake-Barriers.pdf?hsLang=en)

---

![dermatology](https://resources.within3.com/hs-fs/hubfs/dermatology.png?width=400&height=486&name=dermatology.png "dermatology")

## 2. Dermatology

## Defending Market Position Through Real-Time Insight

### A dermatology team used real-time competitive intelligence to see where new entrants were gaining ground, and moved before it showed up in market-share data.

[Read More](https://resources.within3.com/hubfs/2026%20-%202H%20-%20ROI%20Commercial%20Use%20Cases%20(4%20of%204)/W3-One-Pager-Use-Case-Defending-Market-Position.pdf?hsLang=en)

---

![rare-disease-1](https://resources.within3.com/hs-fs/hubfs/rare-disease-1.png?width=400&height=486&name=rare-disease-1.png "rare-disease-1")

## 3. Rare Disease

## Maximizing Evidence Impact in Rare Diseases

### A rare disease team used precision intelligence to turn specialist awareness into prescribing action in one of pharma's most complex markets.

[Read More](https://resources.within3.com/hubfs/2026%20-%202H%20-%20ROI%20Commercial%20Use%20Cases%20(4%20of%204)/W3-One-Pager-Use-Case-Maximizing-Evidence-Impact.pdf?hsLang=en)

---

![rare-disease-2](https://resources.within3.com/hs-fs/hubfs/rare-disease-2.png?width=400&height=486&name=rare-disease-2.png "rare-disease-2")

## 4. Rare Disease

## Revealing the Hidden Patient Landscape 

### A rare disease launch team used claims data and patient community intelligence to uncover where patients were being missed, and why.

[Read More](https://resources.within3.com/hubfs/2026%20-%202H%20-%20ROI%20Commercial%20Use%20Cases%20(4%20of%204)/W3-One-Pager-Use-Case-Hidden-Patient-Landscape.pdf?hsLang=en)

## See what Launch Intelligence™ could surface for your brand

### Within3 helps Commercial, Medical Affiars & Market Access teams create, capture, and connect the signals that matter. A living intelligence that moves your strategy ahead. Trusted by 70+ biotechs and all of the top 20 pharmaceutical companies.

[Request a Demo](https://within3.com/book-a-demo)

[Follow us on Facebook](https://www.facebook.com/within3) [Follow us on LinkedIn](https://www.linkedin.com/company/within3) [Follow us on Twitter](https://twitter.com/Within3)

© 2026 Within3